ARTICLES BY ALEXANDER K. AUST
Draft FDA Labeling Guidance Proposes More Clarity For Providers3/7/2023
The FDA's draft guidance for prescription and biologic drugs updates a 2010 guidance and comes following the boom of activity in the biologics space. This article breaks down and analyzes the update on labeling for prescription drugs and biologics on an increasingly complex landscape.
6 Strategies To Protect Your Biologics Supply Chain In 20231/25/2023
Instead of automating everything — which costs a lot and doesn't solve every problem — drug makers should focus on building scalable, need-specific supply chain operations. This article discusses supply chain resilience strategies biotech companies can reasonably control.